Insights into the unusual Alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 148-156

  Low, A M ^b   Lu Chao, H ^b   Loke, J C P ^a,b   Kwan, C Y ^b   Daniel, E E ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; PHENOXYBENZAMINE; RAUWOLSCINE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; DOG; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ALKYLATING AGENTS; ALKYLATION; ANIMALS; AZEPINES; BINDING, COMPETITIVE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; PHENOXYBENZAMINE; PHENYLEPHRINE; PRAZOSIN; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, ALPHA-2; SAPHENOUS VEIN; YOHIMBINE;

EID: 0032912538     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Alabaster VA, Keir RF and Peters CJ (1985) Comparison of activity of α-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein. Naunyn-Schmiedeberg's Arch Pharmakol 330:33-36.
2. Beckeringh JJ, Zerkowski H-R, Rohm N and Brodde O-E (1987) α-Adrenoceptors in preparations of the human saphenous vein. J Cardiovasc Pharmacol 10 (Suppl 4):S91-S93.
3. 1-adrenoceptors in dog saphenous vein exposed to phenoxybenzamine. Eur J Pharmacol 85:325-329.
4. Daniel EE, Low AM, Gaspar V, Lu-Chao H, Green J, Akrong J, Duerksen S, Soyka C, Chen CK, Boyd J and Kwan CY (1996) Unusual α-adrenoceptor subtype in canine saphenous vein: comparison to mesenteric vein. Br J Pharmacol 117:1535-1543.
5. Daniel EE, Low AM, Lu-Chao H, Gaspar V and Kwan CY (1997) Characterization of α-adrenoceptors in canine mesenteric vein. J Cardiovasc Pharmacol 30:591-598.
6. 2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48:875-884.
7. 2-adrenergic receptors to two G-proteins with opposing effects. J Biol Chem 267:15795-15801.
8. Eskinder H, Hillard CJ, Olinger GN, Christensen CW, Baker JE, Warltier DC and Gross GJ (1988) Alpha-adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: Sensitivity to blockade by nitroglycerin. J Pharmacol Exp Ther 247:914-948
9. Flavahan NA and Vanhoutte PM (1986) Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins. J Pharmacol Exp Ther 238:131-138.
10. Fowler PJ, Grous M, Price W and Matthews WD (1984) Pharmacological differentiation of postsynaptic alpha-adrenoceptors in the dog saphenous vein. J Pharmacol Exp Ther 229:712-718.
11. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors): An evaluation from the standpoint of receptor theory, in Hand Book of Experimental Pharmacology: Catecholamines (Blaschko M and Muscholl E eds) vol 33, pp 283-335, Springer-Verlag, New York.
12. Guimaraes S, Paiva MQ and Moura D (1987) An α-2-adrenoceptor-mediated responses to so-called selective α-1-adrenoceptor agonists after partial blockade of α-1-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmakol 335:397-402.
13. Hicks PE, Barras M, Herman G, Mauduit P, Armstrong JM and Rossignol B (1991) α-Adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production. Br J Pharmacol 102:151-161.
14. Kenakin T (1995) Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci 18:188-192.
15. Low AM, Bowdish DM, Prashad TR and Gaspar V (1994) Interactions of chloroethylclonidine with rauwolscine- and prazosin-sensitive adrenoceptors in dog saphenous vein. Br J Pharmacol 113:1263-1268.
16. Nunes JP and Guimaraes S (1993) Chloroethylclonidine irreversibly activates postjunctional α2-adrenoceptors in the dog saphenous vein. Naunyn-Schmiedeberg's Arch Pharmakol 348:264-268.
17. Ruffolo RR Jr and Zeid RL (1985) Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein. J Pharmacol Exp Ther 235:636-643.
18. max) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues. J Pharmacol Exp Ther 250:1119-1124.
19. s-coupled receptors and dependent on receptor density. Mol Pharmacol 46:460-469.